ALX Oncology Ownership | Who Owns ALX Oncology?
ALX Oncology Ownership Summary
ALX Oncology is owned by 17.41% institutional investors, 0.92% insiders, and 81.67% retail investors. Tcg crossover management is the largest institutional shareholder, holding 24.25% of ALXO shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 6.38% of its assets in ALX Oncology shares.
ALXO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | ALX Oncology | 17.41% | 0.92% | 81.67% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Tcg crossover management | 13.01M | 24.25% | $26.09M |
| Ra capital management | 13.01M | 24.25% | $26.09M |
| Venbio partners | 12.88M | 24.01% | $25.83M |
| Redmile group | 7.96M | 14.84% | $15.97M |
| Blackstone | 5.83M | 10.86% | $11.71M |
| Driehaus capital management | 5.73M | 10.69% | $11.50M |
| Marshall wace, llp | 3.76M | 7.00% | $7.51M |
| Vivo capital | 3.18M | 5.94% | $6.39M |
| Almitas capital | 3.17M | 5.91% | $6.36M |
| 5am venture management | 3.06M | 5.70% | $6.13M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Venbio partners | 12.88M | 9.21% | $25.83M |
| 5am venture management | 3.06M | 1.70% | $6.13M |
| Almitas capital | 3.17M | 1.44% | $6.36M |
| Redmile group | 7.96M | 1.06% | $15.97M |
| Caxton | 20.95K | 1.04% | $42.00K |
| Tcg crossover management | 13.01M | 0.75% | $26.09M |
| Vivo capital | 3.18M | 0.53% | $6.39M |
| Ra capital management | 13.01M | 0.28% | $26.09M |
| Orbimed advisors | 2.87M | 0.11% | $5.75M |
| Driehaus capital management | 5.73M | 0.08% | $11.50M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | 13.01M | 0.28% | 13.01M |
| Tcg crossover management | 13.01M | 0.75% | 13.01M |
| Blackstone | 5.83M | 0.05% | 5.83M |
| Redmile group | 7.96M | 1.06% | 4.70M |
| Driehaus capital management | 5.73M | 0.08% | 4.31M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | - | - | -3.60M |
| Tang capital management | - | - | -3.16M |
| Cormorant asset management, lp | - | - | -3.14M |
| Paradigm biocapital advisors lp | - | - | -1.58M |
| Millennium management | 1.99M | 0.00% | -1.22M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ra capital management | 13.01M | 0.28% | 13.01M | $26.09M |
| Tcg crossover management | 13.01M | 0.75% | 13.01M | $26.09M |
| Blackstone | 5.83M | 0.05% | 5.83M | $11.71M |
| Vivo capital | 3.18M | 0.53% | 3.18M | $6.39M |
| 5am venture management | 3.06M | 1.70% | 3.06M | $6.13M |
Sold Out
| Holder | Change |
|---|---|
| Srs capital advisors | -2.00 |
| Allspring global investments | -2.00 |
| Farther finance advisors | -4.00 |
| Creekmur asset management | -4.00 |
| Gamma investing | -12.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 34 | -45.16% | 9,343,336 | -68.01% | 17 | 0.59% | 15 | -37.50% | 9 | -43.75% |
| Dec 31, 2025 | 11 | -82.54% | 2,731,277 | -90.17% | 5 | 0.19% | 4 | -76.47% | 2 | -93.75% |
| Sep 30, 2025 | 18 | -71.43% | 2,395,272 | -91.76% | 4 | 0.15% | 4 | -80.00% | 8 | -75.00% |
| Jun 30, 2025 | 63 | -26.74% | 29,075,912 | -13.08% | 54 | 1.38% | 20 | -39.39% | 32 | 10.34% |
| Mar 31, 2025 | 86 | -7.53% | 34,801,922 | -15.26% | 65 | 1.07% | 34 | -35.85% | 29 | 38.10% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| HBM Healthcare Investments AG Ord | 8.59M | 6.38% | 3.82M |
| Vanguard Total Stock Mkt Idx Inv | 3.64M | 2.71% | - |
| Vanguard US Total Market Shares ETF | 984.59K | 1.84% | - |
| Fidelity Select Biotechnology | 835.50K | 1.58% | - |
| Fidelity Stock Selector Small Cap | 837.11K | 1.57% | 10.71K |
| Fidelity Series Small Cap Opps | 769.53K | 1.44% | - |
| Fidelity Small Cap Value Fund | 678.40K | 1.29% | - |
| Fidelity Small Cap Growth | 432.37K | 0.82% | -1.26M |
| Fidelity Small Cap Index | 348.14K | 0.65% | - |
| Biotech Growth Ord | 694.70K | 0.52% | -231.60K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 19, 2026 | Lettmann Jason | CHIEF EXECUTIVE OFFICER | Sell | $26.71K |
| Mar 19, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | $1.96K |
| Feb 18, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | $1.28K |
| Feb 02, 2026 | GOODMAN COREY S | Buy | $5.00M | |
| Jan 06, 2026 | Pinto Shelly | SVP, FINANCE AND CAO | Sell | $4.36K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | 1 | 4 |
| 2025 Q4 | - | - |
| 2025 Q3 | 3 | 3 |
| 2025 Q2 | - | 1 |
ALXO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools